BIOPHARMACEUTICS influence of formulation on THERAPEUTIC ACTIVITY 1. DEFINITIONS, SCOPE and relationship to GASTROINTESTINAL PHYSIOLOGY.
Wagner
John G
JG
Clinical Pharmacology Phase 1, Medical Research Division, The Upjohn Company, Kalamazoo, Mich., USA.
D001702:Biopharmaceutics; D004068:Digestive System Physiological Phenomena / Q000187:drug effects*; D016503:Drug Delivery Systems; D004358:Drug Therapy; D006801:Humans; D004364:Pharmaceutical Preparations / Q000378:metabolism
D004364:Pharmaceutical Preparations